Part D Precription Drug

The $9 billion in Extra Cash From Medicare

Posted on

On January 4, 2019 the Wall Street Journal published a powerful article written by Joseph Walker and Christopher Weaver describing how Medicare Part D insurers kept $9.1 billion more in taxpayer funds than they would have had their estimates been accurate from 2006 to 2015. In the WSJ  article, the writers do a deep dive […]

Medicare

Medicare Cards are Changing

Posted on

Medicare is removing Social Security Numbers from Medicare cards Congress in 2015 passed a law requiring Medicare to stop using Social Security numbers and come up with a way to protect seniors from identity theft. The new Medicare numbers will be a randomly generated sequence of 11 numbers and letters. Beginning April 2018, Medicare will […]

Part D Precription Drug

Is the new Novo Nordisk “improved” insulin worth a 60-70% price hike? The market says ‘no.’

Posted on

My clients regularly ask why brand name medications are so expensive. This great article by WSJ reporter Denise Roland helps explain the game. “In traditional marketing, a product line extension is the use of an established brand name for a new item with new flavors, forms, colors, added ingredients, package sizes.” Novo Nordisk repackaged its […]